21 – 30 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Astrocytic expression of GSTA4 is associated to dopaminergic neuroprotection in a rat 6-OHDA model of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Strategies for bringing stem cell-derived dopamine neurons to the clinic : A European approach (STEM-PD)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
(
- Contribution to journal › Article
- 2016
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
2016)(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
-
Mark
Developing stem cell therapies for Parkinson's disease : waiting until the time is right
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
(
- Contribution to journal › Article
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial